Related Experiment Video
Updated: May 24, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Revisiting antimicrobial stewardship in the paediatric intensive care unit: insights from an unconventional approach
C Liberati1, G Brigadoi1, E Gres2
1Division of Paediatric Infectious Diseases, Department of Women's and Children's Health, University of Padova, Padova, Italy.
Insights
An antimicrobial stewardship programme (ASP) in a paediatric intensive care unit (PICU) significantly reduced overall antibiotic consumption by 3.0% monthly. This initiative highlights the importance of antimicrobial stewardship for critically ill children.
Area of Science:
- Pediatric Intensive Care
- Antimicrobial Stewardship
- Infectious Disease Management
Background:
- Patients in pediatric intensive care units (PICUs) are at high risk for inappropriate antimicrobial prescriptions.
- This study evaluates an antimicrobial stewardship programme (ASP) implemented in an Italian tertiary hospital's PICU.
Purpose of the Study:
- To describe the implementation and effectiveness of an antimicrobial stewardship programme (ASP) in a pediatric intensive care unit (PICU).
- To assess the impact of the ASP on antibiotic consumption in critically ill children.
Main Methods:
- A pre-post quasi-experimental study was conducted from January 2019 to December 2022.
- An ASP intervention was implemented in February 2021 using a multi-disciplinary 'handshake' approach.
- Antibiotic consumption (DOTs/1000 patient-days) was analyzed using interrupted time series analysis.
Main Results:
- Overall antibiotic consumption decreased by 3.0% monthly post-intervention (P<0.0001).
- Significant monthly reductions were observed for meropenem (4.9%), glycopeptides (3.8%), and piperacillin-tazobactam (4.8%).
- Consumption of third-generation cephalosporins and amikacin remained unchanged.
Conclusions:
- The implemented ASP was effective in reducing antimicrobial consumption within the PICU setting.
- These findings underscore the critical role of antimicrobial stewardship in managing infections in critically ill children.
Background:
Patients admitted to the paediatric intensive care unit (PICU) constitute a high-risk group with increased likelihood of receiving inappropriate antimicrobial prescriptions. This study describes an antimicrobial stewardship programme (ASP) in the PICU of a tertiary hospital in Italy.
Method:
A pre-post quasi-experimental study was conducted between 1st January 2019 and 31st December 2022 in the PICU of the Department for Women's and Children's Health, University Hospital of Padova. The ASP intervention was implemented in February 2021 by a multi-disciplinary team using the 'handshake' approach. The population included all patients admitted to the PICU. The primary outcome was antibiotic consumption measured as days of therapy administered (DOTs)/1000 patient-days. An interrupted time series analysis was used to assess trends in antibiotic prescribing before and after the intervention.
Results:
In total, 616 patients (episodes) were admitted in the pre-intervention phase (January 2019-January 2021) and 602 patients were admitted in the post-intervention phase (February 2021-December 2022). Implementation of the ASP resulted in a significant decrease in overall antibiotic consumption by 3.0% every month (P<0.0001). Monthly reductions in higher consumption antibiotics were: meropenem, 4.9% (P=0.009); glycopeptides, 3.8% (P=0.014); and piperacillin-tazobactam 4.8% (P=0.034). The consumption of third-generation cephalosporins and amikacin did not change significantly.
Conclusions:
The ASP intervention was effective in reducing the consumption of antimicrobials in this complex setting. These results show the importance of antimicrobial stewardship in the scenario of critically ill children.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Antibiotic Selection

